1 |
PR-104A substance being studied in the treatment of cancer. PR-104 becomes active when cancer cells don’t receive enough oxygen. It may kill cancer cells by damaging their DNA.
|
2 |
PR-104A substance being studied in the treatment of cancer. PR-104 becomes active when cancer cells don’t receive enough oxygen. It may kill cancer cells by damaging their DNA.
|
<< PR+ | practitioner >> |